repurposing semaglutide and liraglutide for alcohol use disorder GLP‐1 Receptor Agonists Treating Disorder: A Critical Review - Woo - 2026 - Alcohol, Clinical Experimental Research Could GLP-1 Weight Loss Drugs

31 , 564579.e7 (2020)

Im not sure why there isnt a warning [for gastroparesis] yet. (During the September presentation of scientific evidence, representatives for Novo Nordisk noted that Etminan and his co-authors are not gastroenterologists and said their study was not enough to establish cause and effect.) Eli Lillys warning label for Mounjaro says it can cause severe gastrointestinal problems and is not recommended for patients with preexisting gastroparesis, but the label doesnt explicitly list gastroparesis as a possible side effect

It also keeps the weight off for good

(2014) has shown that IGF-1R is one of direct targets of miR-99a in OSCC, which has been reported in several studies to be downregulated in clinical samples of OSCC in different stages (Yan et al., 2012)

Symptoms are often dose-dependent and may improve over time as the body adjusts to the medication

Curr Hepatology Rep 2020;19: 6369